Stericycle Inc. (NASDAQ:SRCL) shares fell 0.9% on Friday . The stock traded as low as $84.35 and last traded at $84.60, with a volume of 363,506 shares trading hands. The stock had previously closed at $85.36.

Several brokerages have recently weighed in on SRCL. Zacks Investment Research downgraded shares of Stericycle from a “buy” rating to a “hold” rating in a research note on Monday, July 25th. Jefferies Group restated a “buy” rating and issued a $125.00 target price (down from $140.00) on shares of Stericycle in a research note on Friday, July 29th. Wellington Shields downgraded shares of Stericycle from an “accumulate” rating to a “hold” rating in a research note on Friday, July 29th. Imperial Capital downgraded shares of Stericycle from an “in-line” rating to an “underperform” rating and decreased their target price for the company from $100.00 to $93.50 in a research note on Friday, July 29th. Finally, Royal Bank Of Canada restated a “sell” rating on shares of Stericycle in a research note on Thursday, May 26th. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $118.15.

The stock has a market cap of $7.16 billion and a price-to-earnings ratio of 29.62. The firm has a 50 day moving average price of $92.07 and a 200-day moving average price of $105.31.

Stericycle (NASDAQ:SRCL) last released its quarterly earnings results on Thursday, July 28th. The company reported $1.18 EPS for the quarter, meeting the Zacks’ consensus estimate of $1.18. During the same period in the prior year, the business earned $1.14 EPS. The firm earned $891.60 million during the quarter, compared to the consensus estimate of $910.29 million. The company’s revenue for the quarter was up 24.6% compared to the same quarter last year. Equities analysts expect that Stericycle Inc. will post $4.69 earnings per share for the current year.

In other news, Director Rodney F. Dammeyer sold 10,188 shares of Stericycle stock in a transaction that occurred on Wednesday, August 17th. The shares were sold at an average price of $85.50, for a total value of $871,074.00. Following the transaction, the director now owns 10,188 shares of the company’s stock, valued at $871,074. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Mark C. Miller sold 34,835 shares of Stericycle stock in a transaction that occurred on Friday, July 8th. The shares were sold at an average price of $104.52, for a total transaction of $3,640,954.20. Following the completion of the transaction, the director now directly owns 244,284 shares in the company, valued at approximately $25,532,563.68. The disclosure for this sale can be found here.

A hedge fund recently raised its stake in Stericycle stock. US Bancorp DE boosted its position in shares of Stericycle Inc. (NASDAQ:SRCL) by 33.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 229,894 shares of the company’s stock after buying an additional 57,322 shares during the period. US Bancorp DE owned 0.27% of Stericycle worth $27,725,000 as of its most recent SEC filing.

Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.